title: Cyclosporine in psoriasis: comparison of a 25-year real-world Italian experience to current European guidelines.
abstract: Cyclosporine (CsA) is an effective and safe therapeutic option in various dermatoses in both adults and children. Over the last 25 years, Italian dermatologists have gained relevant experience about the use of CsA in the treatment of psoriasis and atopic dermatitis, and an Italian Consensus Conference has recently provided recommendations in adult patients. A comparison between these real-world indications and current European guidelines is hereby provided.
authors: Galeazzi Institute for Scientific Research, University of Milan, Milan, Italy - giampiero.girolomoni@univr.it.
authors: Gianfranco
authors: G
authors: Altomare
authors: Fabio
authors: F
authors: Ayala
authors: Federico
authors: F
authors: Bardazzi
authors: Gilberto
authors: G
authors: Bellia
authors: Sergio
authors: S
authors: Chimenti
authors: Delia
authors: D
authors: Colombo
authors: Maria L
authors: ML
authors: Flori
authors: Giampiero
authors: G
authors: Girolomoni
authors: Giuseppe
authors: G
authors: Micali
authors: Aurora
authors: A
authors: Parodi
authors: Ketty
authors: K
authors: Peris
authors: Gino A
authors: GA
authors: Vena
mesh_terms: D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000473:pathology; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005060:Europe; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007558:Italy; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016572:Cyclosporine